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105P Glycolytic enzymes lactate dehydrogenase A (LDHA) and
phosphofructokinase P (PFKP) are good biomarkers of survival and
potential therapeutic targets in cervical cancer
L.V. Bola~nos1, A.M. Espinoza2, A. Alfaro2, E.V. Barron2, E. Juarez2, J. Berumen Campos2
1Medicina Genomica, Universidad Nacional Autonoma de Mexico, Mexico City, Mexico,
2Hospital General de Me´xico, Mexico City, Mexico
Background: Cervical Cancer (CC) is the fourth most common cancer in women
worldwide. Potential biomarkers in cancer can be identified by considering the changes
in tumoral glycolysis. In this work, we investigated whether the expression of some
glycolytic enzymes is associated with the overall and disease-free survival of patients
with CC.
Methods:We analyzed the expression of 14 genes related with glycolysis (SLC2A1,
ADPGK, ALDOA, EDARADD, ENO1, GAPDH, GPI, HK2, LDHA, PFKP, PGK1,
PKM, TPI1P1, SLC9A1) in 67 CC, 10 high-grade cervical intraepithelial neoplasia
(HG-CIN) and 17 healthy cervical epitheliums (HCE), as controls, with the Human
Gene 1.0 STMicroarray (HG 1.0 ST). Validation of gene expression of LDHA and
PFKP was performed by qRT-PCR and immunohistochemistry. The expression of
LDHA and PFKP was correlated with 5-year survival of CC patients by the Kaplan-
Meier method, and FIGO staging and the gene expression were included as covariates
in a Cox proportional hazard model.
Results: The amount of the mRNA transcribed from the 14 glycolytic genes was higher
in CC tumors than in HG-CIN andHCE. Overexpression of genes TPI1P1, LDHA,
PFKP, GAPDH, GPI, PGK1 was associated with poor survival, but only the overexpres-
sion of LDHA and PFKP genes was independent of the FIGO stage. The qRT-PCR
assays confirmed that the overexpression of LDHA and PFKP were associated with
poor overall survival (LDHA p= 0.004, PFKP p¼ 0.0043, Long-rang test) and disease-
free survival (LDHA p¼ 0.001, PFKP p= 0.013, Long-rang test) in an independent
fashion of the FIGO stage (LDHA p¼ 0.050, PFKP p¼ 0.029, Cox proportional-
hazards regression). Interestingly, only the protein encoded by LDHA gene, analyzed
by immunohistochemistry, showed a significant higher expression in recurrent than in
non-recurrent tumors.
Conclusions:Our results indicate that the expression of LDHA and PFKP at the
mRNA and protein levels may be good biomarkers for overall and disease-free survival,
independent of FIGO clinical stage, and could be potential therapeutic target for CC.
Legal entity responsible for the study:Conacyt, Mexico.
Funding:Has not received any funding.
Disclosure: All authors have declared no conflicts of interest.
106P Experience of 22 patients with ROS mutated lung adenocarcinoma
treated with crizotinib at a tertiary care center in India
V. Talreja1, N. Pande2
1Medical Department, Tata Memorial Hospital Centre, Mumbai, India, 2Medical
Oncology, Tata Memorial Hospital Centre, Mumbai, India
Background: ROS1 hence became recognized as a distinct molecular target in
NSCLC.Like ALK rearrangements ROS1 fusions are also foundmore in never smokers
but define a distinct molecular subgroup with both rarely occurring together in same
patient Crizotinib, a highly effective inhibitor of ROS1 kinase activity, is now FDA-
approved for the treatment of patients with advanced ROS1-positive NSCLC .We
report our experience in a tertiary cancer care centre in ROS-1 positive patients.
Methods: The present study was a retrospective analysis of a prospectively maintained
lung cancer registry in whom the ROS1mutation status was determined.Genetic
Assessments for ROS1 and ALK rearrangements were identified by using FISH.All stat-
istical analyses were carried out using the SPSS software version 22.0.
Results: Between January 2015 and December 2017 there were 22 patients who were
positive for ROS gene rearrangement. A total of 16 patients took Crizotinib either in
first or second line.There were 13male(60%) and 9 females(40%) in the cohort whose
median age was 54 years.The median follow up in Crizotinib received arm was 322 days
and 244 days in non-Crizotinib arm.Among the 16 patients who received Crizotinib,
2(12.5%) achieved (CR) as their best response and continue to remain in CR at follow
up.13(81.2%) had (PR) as best response and of which on follow up 5 have progressed
while 8 continue to maintain response.The median follow-up was 244 days.The esti-
mated medianPFS for the entire cohort of patients was 4 months(95%CI:2.5–5.5
months).The estimatedmedian PFS for the ROSmutant patients was significantly lon-
ger at 573 Days(95%CI:318-544 days) as compared to the estimatedmedian PFS for
ROS negative patients which was 79 days(95%CI:43-201 days),p¼0.00.The estimated
median OS for all patients was 13months(95%CI:10.7–15.3months).The estimated
median OS for ROS positive patients was not achieved (95%CI:2.4–25.6 months),
while that for ROS negative patients was 79 days (95%CI:7.4–12.6months),p¼ 0.001.
Conclusions: ROS1 rearrangement with incidence of 4% of lung adenocarcinoma rep-
resents a important targetable driver mutation in Indian population. Crizotinib is effec-
tive treatment option with acceptable side effects in our population.
Legal entity responsible for the study: TataMemorial Hospital.
Funding:Has not received any funding.
Disclosure: All authors have declared no conflicts of interest.
107P Computational integrative analysis of identification of potential
therapeutic genes and networks in breast cancer
M. Peer Mohammed1, V. Parthasarathy2
1Bioinformatics Infrastructure Facility Centre of DBT, Presidency College, Chennai, India,
2Nanoscience and Technology, Bharathiar University, Coimbatore, India
Background: Cancer genomics research aims at investigation of biological pathways
affected bymutations of these genes will help us to understand the determinants of can-
cer initiation, progression, and other biological functions. The sophisticated computa-
tional methods have been developed to facilitate the detection of cancer driver
mutations and pathways. Wemade an attempt in this study to identify the potential
candidate genes in the breast cancer carcinogenesis by computational integrative analy-
sis. This approach is appropriated for identifying potentially useful diagnostic and
prognostic biomarkers for therapeutic intervention of breast cancer.
Methods: Breast cancer tissue microarray datasets were retrieved fromGene
Expression Omnibus database (GEO) and the upregulated and downregulated genes
were analyzed. Gene ontology, pathway analysis and coexpression network patterns
identification were performed.
Results: A total of 1760 Differential Expressed Genes were identified, including 1083
upregulated and 677 downregulated genes. The Gene Ontology terms for molecular
functions, biological processes, and cellular component were protein binding, small
molecule metabolic process, and integral to membrane, respectively. Themost signifi-
cant pathway in BIOCARTAwas DNA replication & repair and cell division regulation
pathways. Protein to protein network analysis indicated that the significant hub genes
including ARD1,AURKB, AIK2, AIM1, ARK2, AurB, IPL1, STK5, AIM-1, STK12,
PPP1R48, aurkb-sv1, aurkb-sv2, CEP55, CT111, URCC6, C10orf3,MELK ,
HPK38,FOXA1,HNF3A, TCF3A,ARA, IGDA, IHG1, FKHL7, IRID1, RIEG3,
FREAC3,ACKR1, CCBP1, CD234,WBCQ1 , PIR- FIGF and BAI1 associated protein
2(BAIAP2) . Gene coexpression network analysis identified 4major modules,Ankyrin
repeat domains,Forkhead box C1,Forkhead box A1 and Trefoil factor 3.
Conclusions:Our study concludes a comprehensive view of integrative analysis of gene
expression patterns associated with the breast cancer onset and progression.
Legal entity responsible for the study:M. PeerMohammed.
Funding:Has not received any funding.
Disclosure: All authors have declared no conflicts of interest.
108P The effect of the seleno-L-methionin, sodium selenite and cadmium
chloride on telomerase activity of chick embryo neural tube cells
H. Akhavan1, S.S. Hosseini-Asl1, H. Abbasgholizadeh1, M. Sagha2
1Genetics, Ardabil University of Medical Sciences, Ardabil, Iran, 2Anatomy, Ardabil
University of Medical Sciences, Ardabil, Iran
Background: Telomerase is a ribonucleoprotein enzyme with reverse transcriptase
activity, that more important in developmental processes including cell proliferation,
differentiation, senescence and tumorigenesis. Selenium as a trace element for animals
and human has been detected which can have anticancer properties, while cadmium
(Cd) is a heavymetal in the natural environment and is very toxic. Purpose of this study
was investigating the effects of Seleno-L-methionine, Sodium selenite and Cadmium
chloride on the expression of telomerase activity in Chick embryo neural tube.
Methods:Using quantitative and qualitative methods RTQ- TRAP and TRAP assay,
the effect of the noted elements on the telomerase activity of Chick embryo neural tube
was studied.
Results:Unlike expected, seleno-L-methionine increased telomerase activity.
Cadmium chloride had the greatest effect on telomerase activity, while the effect of
Sodium selenite was lower than two others. However, the increasing effect has been
determined.
Conclusions: All three compounds at concentration of 5 lMand effect time of 6 hours
hadmost impact on Chick embryo neural tube telomerase activity compared to the
control groups. Cadmium chloride had greatest effect and sodium selenite were less
effective.
Legal entity responsible for the study:Ardabil University of Medical Sciences.
Funding:Has not received any funding.
Disclosure: All authors have declared no conflicts of interest.
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